NEU 7.18% $14.47 neuren pharmaceuticals limited

in regard to his valuations, I am very aware that the market...

  1. 930 Posts.
    lightbulb Created with Sketch. 313
    in regard to his valuations, I am very aware that the market does not operate in accordance with my gut, but I was very interested to read his base case, absurdly discounted valuation of $10.6b USD up to $22b USD.

    I have long had a gut feeling that we will be sold for $15b USD and that sits very close to in the middle of those two valuations. That’s of no relevance/significance but I found it interesting nonetheless.

    The valuations blow my mind and looking at other non-orphan conditions it could possibly treat, it would make $22b USD look like a giveaway price.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.